Mr. Daniel D. Burgess is Partner at SV Life Sciences Advisers LLP, Independent Director at Cidara Therapeutics, Inc., President, Chief Executive Officer & Director at Rempex Pharmaceuticals, Inc., and Chairman at AtoxBio, Inc.
He is on the Board of Directors at Cidara Therapeutics, Inc., Rempex Pharmaceuticals, Inc., BIOCOM, and Arsanis, Inc.
Mr. Burgess was previously employed as President & Chief Executive Officer by Mpex Pharmaceuticals, Inc., Independent Director by Santarus, Inc., Chief Operating & Financial Officer by Harbor BioSciences, Inc., Chief Financial Officer & Vice President by Nanogen, Inc., Chief Financial Officer & Vice President by SICOR, Inc., Financial Analyst by Smith Barney Harris Upham & Co., Inc., President by Gensia Automedics, Inc., and a Principal by Castle & Cooke, Inc.
He also served on the board at Metabasis Therapeutics, Inc.
He received his undergraduate degree from Stanford University and an MBA from Harvard Business School.